Core Points - TELA Bio, Inc. announced the approval of an inducement grant of stock options and restricted stock units to Jim Hagen, the Senior Vice President of Strategic Commercial Operations, as part of his employment compensation [1][2] - The stock options have an exercise price of $1.42 per share, with a ten-year term and a vesting schedule over four years [2] - TELA Bio focuses on innovative soft-tissue reconstruction solutions that prioritize the preservation and restoration of the patient's own anatomy [3] Summary by Category Inducement Grant Details - The Compensation Committee approved an option to purchase 75,000 shares and restricted stock units covering 30,000 shares for Jim Hagen [1] - The stock options will vest 25% on the first anniversary of the grant date, with the remaining 75% vesting in equal monthly installments over the following 36 months [2] - The restricted stock units will vest in equal annual installments over four years [2] Company Overview - TELA Bio is a commercial-stage medical technology company [3] - The company aims to provide advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response [3] - TELA Bio minimizes long-term exposure to permanent synthetic materials in its solutions [3]

PETACH TIKVA, Israel, June 06, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will host a conference call and webcast to report topline data for the SHIELD II Phase 3 trial, evaluating D-PLEX100 for the prevention of surgical site infections in patients undergoing abdominal colorectal surgery, on Monday, June 9, at 8:30 a.m. ET. To ensure you are connected prior to the beginning o ...

New York, NY , June 06, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today that on June 5, 2025, it caused to be deposited $0.15 per public share, totaling $10,890.15 (the “Extension Payment”) into its trust account (the “Trust Account”) with Continental Stock Transfer and Trust Company (“Continental”) to extend the deadline to complete its initial business combination from June 9, 20 ...

LEXINGTON, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ß”) family of proteins, today announced that Keros’ Chair and Chief Executive Officer Jasbir S. Seehra, Ph.D., will participate in a fireside chat presentation at the G ...

SKEL has signed purchase agreements with a group of domestic institutional investors for their acquisition of 153.9 million shares in Styrkás hf., representing just over 15.4% of the company’s issued share capital. The total purchase price of the shares is ISK 3,150 million, equivalent to ISK 20.47 per share. The sale price is equal to the book value of SKEL’s stake in Styrkás as of December 31, 2024. The purchase agreements are subject to customary conditions, which are expected to be finalized next week. ...

Group 1 - The Supervisory Board of Silvano Fashion Group AS approved the annual report for the financial year 2024 on 06 June 2025 [1] - The consolidated audited Annual Report for 2024 is available on the websites of Nasdaq Baltic and Silvano Fashion Group [1]

MCLEAN, Va., June 06, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions and AI, announces continued listing and trading of its shares of common stock and warrants on NASDAQ. On June 5, 2025, the SEC filed a Form 25 notification of removal from listing and/or registration under Section 12(b) of the Securities Exchange Act of 1934 regarding the Units previously listed and registered by Western Acquisition Ventures Corp, the pre ...

ORLANDO, Fla., June 06, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced that its Board of Directors has authorized a new $20 million share repurchase program, effective June 5, 2025 for over a period of up to 18 months, as well as recent Form 4 and other employee share purchases totaling over $2 million. "While it is unfortunate that Abacus Global Management has been subject to a short atta ...

Group 1 - The article discusses the allocation of shares under the variable remuneration policy for individuals with managing responsibilities at Banco Comercial Português, S.A. [1] - This allocation is part of the company's strategy to incentivize and reward key management personnel [1] - The announcement highlights the importance of aligning management compensation with company performance [1]

Core Viewpoint - VS Media Holdings Limited has successfully closed a public offering of 4,774,235 ordinary shares at a price of $0.229 per share, generating additional gross proceeds of $1,093,300, which supplements a previous offering announced on May 30, 2025 [1] Group 1: Offering Details - The total gross proceeds from the two closings of the offering amounted to $9,176,100, with net proceeds of $8,401,749 after deducting placement agent fees and other expenses of $774,351 [2] - The total number of issued ordinary shares has increased to 40,070,298, all priced at $0.229 per share [1] Group 2: Regulatory Information - The securities were offered under a registration statement on Form F-1, which was declared effective by the SEC on May 6, 2025, and the offering was made only by means of a prospectus [3] Group 3: Company Overview - VS Media Holdings Limited, founded in 2013, operates a network of over 1,500 digital creators and partners with more than 1,000 brands across Asia Pacific, focusing on content-driven social commerce and effective marketing services [5]